I strongly recommend this article, written by one of the founders of the Cochrane Collaboration, which was set up to aid the systematic use of high quality evidence in medicine:
www.theatlantic.com/health/archive/2021/03/astrazeneca-vaccine-blood-clot-issue-wont-go-away/618451/
She is worried, and she also sets out the complicated dilemmas governments and health professionals face with this. There is still much we don’t know and it’s really really important this is looked at.
The AZ vax is very cheap compared to the others - it’s been provided at cost price. That means our gov has a reason to keep using it (especially as we have pre-ordered so much of it) and yes, probably other pharmaceutical companies have a reason to slam it. None of the information we have at present exists in a nice pure vacuum where these issues are removed.
But, the available evidence as it currently appears is that Az does seem to be correlated with a very specific form of deadly blood clotting which is usually extremely rare. It is wrong to just compare those incidents and deaths to general “blood clotting”. This is a very specific type of clotting.
It’s also wrong to compare the risk of experiencing one of these blood clots to the overall risk from covid. The cases (and deaths) in Europe do seem to be strongly concentrated in women under 55. So the relevant comparator is the risk from covid to women under 55 (and the case rate after the vaccine likewise needs to be compared to the number of women under 55 who have had the AZ, not the total jabs to date).
I also think that with the death rate from these clots being so high in the European cases, we cannot dismiss this as “hyper vigilance” - as something just picked up because people are alert to post vax side effects. This isn’t just a sore arm.
That said, there is still a lot we don’t know. I am usually very pro vax. I remain very pro covid vax, but I want this looked at urgently.
I don’t want this to be yet another thing women are thrown under a bus for. If the gov (and taxpayer) needs to shell out to pay for alternative vaccines for women under 55, then that is what they must do.